BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21996622)

  • 1. Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.
    Zeile I; Gahutu JB; Shyirambere C; Steininger C; Musemakweri A; Sebahungu F; Karema C; Harms G; Eggelte TA; Mockenhaupt FP
    Acta Trop; 2012 Jan; 121(1):50-4. PubMed ID: 21996622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
    Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India.
    Das MK; Lumb V; Mittra P; Singh SS; Dash AP; Sharma YD
    J Antimicrob Chemother; 2010 Jun; 65(6):1258-61. PubMed ID: 20363804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
    Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
    Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
    Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
    Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.
    Foumane Ngane V; Allico Djaman J; Culeux C; Piette N; Carnevale P; Besnard P; Fortes F; Basco LK; Tahar R
    Malar J; 2015 Mar; 14():113. PubMed ID: 25889865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
    Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Evidence for
    Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
    Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.
    Jovel IT; Björkman A; Roper C; Mårtensson A; Ursing J
    Malar J; 2017 Mar; 16(1):113. PubMed ID: 28288632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
    Ogouyèmi-Hounto A; Ndam NT; Fadégnon G; Azagnandji C; Bello M; Moussiliou A; Chippaux JP; Kinde Gazard D; Massougbodji A
    Malar J; 2013 Nov; 12():413. PubMed ID: 24225351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Mandliya J; Sharma A; Diwan V; Ursing J
    Malar J; 2014 May; 13():182. PubMed ID: 24885535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
    Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
    Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.